Researchers bend DNA strands with light, revealing a new way to study the genome
On Sep. 9, 2024, a Princeton University team announced they had developed a way to probe chromosomes and…
On Sep. 9, 2024, a Princeton University team announced they had developed a way to probe chromosomes and…
On Dec. 10, 2022, CSL announced data affirming the long-term durability and safety of single-infusion HEMGENIX® (etranacogene dezaparvovec-drlb)…
On May 18, 2022, the U.S. Department of Agriculture’s (USDA) Animal and Plant Health Inspection Service (APHIS) confirmed…
On Jul. 30, 2020, Seqirus announced it had begun shipping its portfolio of seasonal influenza vaccines to customers…
On May 8, 2020, the FDA issued an emergency use authorization (EUA) to Rutgers Clinical Genomics Laboratory for…
On Apr. 21, 2020,the fight against the coronavirus is underway in a Rutgers UniversityヨCamden research laboratory, where chemistry…
On Apr. 13, 2020, Pluristem Therapeutics announced it has treated its first patient suffering from COVID-19 complications in…
On Feb. 24, 2020, Seqirus announced that the U.S. Food and Drug Administration (FDA) had approved the first…
On Jan. 29, 2020, Sorrento Therapeutics announced it had initiated a clinical and manufacturing collaboration with Celularity, a…
On Dec. 11, 2019, Seqirus announced that its cell-based quadrivalent influenza vaccine (QIVc) had received approval from Health…
On Dec. 5, 2018, Seqirus, a CSL subsidiary, announced real-world data showing that its cell-based quadrivalent influenza vaccine…
On Jul. 6, 2018, Teva Pharmaceuticals announced it would move its U.S. headquarters to Parsippany-Troy Hills, New Jersey…
In 2018, the Lombardi Comprehensive Cancer Center became the 16th National Cancer Institute-designated Comprehensive Cancer Center funded with…
On Oct. 21, 2015, the Omar Boraie Chair in Genomic Science was established at Rutgers Cancer Institute. The…
On Sept. 18, 2015, Stephen J. Elledge from Brigham and Women’s Hospital and Evelyn M. Witkin from Rutgers…
On May 5, 2015, Rutgers Cancer Institute of New Jersey was one of seven international sites to offer…
On Dec. 23, 2014, Juno Therapeutics announced the closing of its initial public offering of 12.7 million shares…
On Sept. 23, 2014, Bristol-Myers Squibb announced plans to build a 650,000-square-foot office building on company-owned land in…
In 2008, the Tisch Cancer Institute (TCI) was founded through the generosity of James and Merryl Tisch. James…
On May 25, 2006, Zostavax, manufactured by Merck & Co. of Whitehouse Station, New Jersey, was approved by…
On Aug. 11, 2005, the Food and Drug Administration (FDA) approved an application of a pediatric/adolescent formulation of…
On May 5, 2001, molecular biologist Shirley M. Tilghman was elected the first woman president of Princeton University….
On Sept. 1, 1999, Princeton University researchers reported that they had genetically modified mice to have improved learning…
In 1997, Bristol-Myers Squibb opened a 433-acre research campus in Hopewell, New Jersey. Two important new medicines co-developed…
In 1994, The Biotechnology Council of New Jersey (BCNJ) was founded. Today, BioNJ is the life sciences trade…
In 1991, the Rutgers Cancer Institute of New Jersey was established at Rutgers, the State University of New…
On Oct. 10, 1989, Ohio University (OU) announced that it had received a patent for a genetic engineering…
In 1982, Merck Frosst Canada was created through the restructuring of Merck & Co., Charles E. Frosst, and…
In 1979, the most frequently mutated gene in human cancer, p53, was identified by six groups of researchers…
In 1978, Johnsonᅠ & ᅠJohnson announced plans to build their new World Headquarters in New Brunswick, New Jersey….